The company said its Board of Directors, on the recommendation of the Compensation Committee on November 18, 2025, approved the 2026 Annual Bonus Plan for the performance year from January 1, 2026 through December 31. The company said the plan is substantially similar to the 2025 annual bonus plan.

1. 01

   The company said its Board of Directors, on the recommendation of the Compensation Committee on November 18, 2025, approved the 2026 Annual Bonus Plan for the performance year from January 1, 2026 through December 31. The company said the plan is substantially similar to the 2025 annual bonus plan.

2. 02

   Boston Scientific said the 2026 Annual Bonus Plan includes an aggregate bonus pool equal to the total target annual bonuses multiplied by the applicable distribution percentage (0% to 150%), as well as a dynamic bonus pool of 10% or less of total target annual bonuses. It said the maximum payout potential for any individual participant is 0% to 225% of the individual's target bonus.

3. 03

   Boston Scientific said its board approved the adoption of two performance share programs on November 18, 2025, the 2026 rTSR PSP and the 2026 Organic Net Sales PSP. It said that if the program criteria are met, performance share awards will be granted to executive officers as restricted stock units under the Amended and Restated 2011 Long-Term Incentive Plan.

4. 04

   The company said both the 2026 rTSR PSP and the 2026 Organic Net Sales PSP measure performance over 3 years, from January 1, 2026 through December 31, 2028. It said the number of performance shares awarded will range from 0% to 200% of each participant's target number of awards.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.